- Poster presentation
- Open Access
Amino acid-based formula affects the gastrointestinal cytokine milieu of children with non-IgE mediated cow’s milk allergy
© Jones et al; licensee BioMed Central Ltd. 2015
- Published: 30 March 2015
- Food Allergy
- Symptom Relief
- Diet Group
- Immune Mediator
- Cytokine Assay
Food Allergy (FA) presents a significant health and economic burden in the western world. Children with non-IgE mediated cow's milk allergy (CMA) are being increasingly seen in clinic. Diagnosis is largely based on delayed onset of symptoms, primarily affecting the gastrointestinal (GI) mucosa. Treatment involves an elimination diet supplemented with amino acid-based formula (AAF) which in some children results in effective symptom relief. To understand the beneficial effects of AAF at the molecular level, herein we characterized the GI cytokine milieu ex vivo from children with or without AAF in their elimination diets.
35 pediatric patients (≤ 5 years) undergoing a diagnostic colonoscopy for their GI symptoms were recruited. Biopsies were collected from the ascending colon. Biopsies were cultured for 24 hours with media only (baseline) or 250µg/ml AAF (Neocate). Supernatants and biopsies were collected and immune mediators quantified by real-time PCR, ELISA and multiplex cytokine assay.
Biopsy supernatants from children with AAF in their diet showed a significant reduction in baseline levels of pro-inflammatory cytokines TNF-α and IL-6 compared to those without AAF. Interestingly, addition of Neocate ex vivo directly reduced IL-1β, IL-6 and TNF-α in biopsies from children without AAF in their diet but not those with AAF. Neocate treatment also led to a significant reduction in epithelial-derived TSLP and IL-33. Similarly, Th2 (IL-4, IL-13) and Treg (IL-10) associated cytokines were significantly reduced in AAF diet group compared to the non-AAF group.
These data provide evidence for the mode of action of AAF on the GI mucosa. The reduction of inflammatory cytokines ex vivo supports the hypothesis that a specific AAF (i.e. Neocate) may have direct anti-inflammatory effects, thus offering one explanation as to how these formula help in non-IgE CMA. Detailed analyses of how AAF affects inflammatory cells are underway .
Written informed consent was obtained from the parent or guardian of the patients for publication of this abstract and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.
- Hartog , et al: Anti-Inflammatory features of the amino acid-based formula Neocate. Clinical and Translational Allergy. 2015Google Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.